Suven Pharma says Casper Pharma completes USFDA pre-approval inspection

Image
Capital Market
Last Updated : Jul 30 2022 | 3:16 PM IST

The US Food and Drug Administration (USFDA) completed a pre-approval inspection at Casper Pharma formulations manufacturing facility situated at GMR Hyderabad SEZ.

Casper Pharma is a wholly-owned subsidiary of Suven Pharmaceuticals, Hyderabad, India.

The inspection was conducted from 25 July through 29 July 2022. The audit is part of the agency's inspection for three product applications filed and slated to be manufactured at this site.

"We are glad to have completed the audit successfully with Zero observations and at the end of the inspection no form 483 was issued by USFDA which signifies compliance and conformance to applicable cGMP regulations," Venkat Jasti, managing director of Suven Pharmaceuticals said in a statement.

In April 2022, the board of Suven Pharma approved acquisition of Hyderabad-based Casper Pharmaceuticals for Rs 155 crore. Casper is engaged in formulations business.

Hyderabad-based Suven Pharmaceuticals is a pure-play contract development and manufacturing company (CDMO) player. Its services include custom synthesis, process R&D, scale-up and contract manufacturing of intermediates, APIs and formulations.

On a consolidated basis, net profit of Suven Pharmaceuticals rose 10.29% to Rs 91.67 crore on 40.40% rise in net sales to Rs 363.85 crore in Q4 March 2022 over Q4 March 2021.

Shares of Suven Pharma rose 2.21% to Rs 481.15 on Friday, 29 July 2022.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 30 2022 | 2:55 PM IST

Next Story